Most types of Ehlers-Danlos syndrome (EDS) are not fatal and do not shorten your lifespan. The major exception is vascular EDS, a rare subtype that carries a median life expectancy of roughly 48 years due to the risk of blood vessel and organ ruptures. Understanding which type you or a loved one has makes all the difference in assessing risk.
Most EDS Types Have a Normal Life Expectancy
There are 13 recognized subtypes of EDS, and the vast majority do not reduce how long you live. The two most common forms, hypermobile EDS and classical EDS, are associated with a normal lifespan. These types cause real, sometimes debilitating problems like chronic joint dislocations, stretchy or fragile skin, and widespread pain, but they don’t typically lead to organ failure or life-threatening emergencies.
That said, “not fatal” doesn’t mean “not serious.” Living with chronic pain, fatigue, and repeated injuries takes a significant toll on quality of life, and these effects deserve attention even when life expectancy itself isn’t shortened.
Vascular EDS Is the Life-Threatening Type
Vascular EDS (vEDS) is fundamentally different from other subtypes. It’s caused by mutations in the gene that produces a key structural protein in blood vessel walls, organ linings, and skin. Without enough functional protein, these tissues become dangerously fragile.
The numbers reflect that fragility clearly. Most people with vascular EDS experience at least one severe complication by age 20. By age 40, the risk of a life-threatening event reaches 80%. Half of those with the condition will live to at least age 48, though a Dutch study of 142 patients found that among those diagnosed first in a family (rather than identified through family screening), the median age at death was 43.
The primary causes of death are arterial dissections and ruptures. The walls of major blood vessels, including the aorta, can tear or burst without warning. The intestines and uterus are also vulnerable to rupture. A ruptured major artery is often fatal, and these events can occur with little or no preceding symptoms.
Pregnancy Risks in Vascular EDS
For women with vascular EDS, pregnancy carries elevated danger. A large review of 565 deliveries found that pregnancy-related deaths occurred in 5.3% of cases. Life-threatening complications, including arterial rupture, uterine rupture, and surgical complications, affected 14.5% of deliveries.
Interestingly, while pregnancy itself is riskier, survival data suggest that women who have been pregnant don’t have worse long-term survival compared to women with vascular EDS who have never been pregnant. The risk is concentrated around the pregnancy and delivery period rather than accumulating over time.
Treatment Can Reduce Vascular Events
There’s no cure for vascular EDS, but medical management can lower the risk of arterial complications. A blood pressure medication called celiprolol has been the standard treatment for years, helping reduce stress on fragile blood vessel walls. More recently, a randomized controlled trial published in Circulation found that adding a second blood pressure drug (an angiotensin receptor blocker) to celiprolol therapy cut the incidence of new arterial events by about 50% over two years. Patients on the combination had arterial complications at roughly half the rate of those on celiprolol alone: 27.6% versus 53.6%.
Beyond medication, people with vascular EDS are typically advised to avoid contact sports, heavy lifting, and other activities that spike blood pressure or risk trauma. Regular imaging to monitor blood vessels for early signs of weakening is also part of ongoing care.
Mental Health and Indirect Risks
Even in the non-vascular types, EDS can affect mortality indirectly through its impact on mental health. Chronic pain, limited mobility, and the frustration of living with a condition that’s often invisible to others create a heavy psychological burden. A chart review of 394 patients seeking EDS assessment at a Toronto clinic found that nearly 1 in 5 (17.8%) reported a past suicide attempt, and almost a third had a history of self-harm.
The study identified two factors beyond pain that were linked to higher risk: symptoms of borderline personality disorder and autonomic dysfunction, the nervous system irregularity that causes dizziness, racing heart, and fainting common in many EDS patients. Joint hypermobility itself, the hallmark feature of EDS, was independently associated with increased self-harm even after accounting for other factors.
These findings highlight that the dangers of EDS aren’t limited to organ rupture. The chronic, daily nature of the condition creates risks that don’t show up in life expectancy statistics but matter enormously. Access to pain management, mental health support, and a medical team that takes symptoms seriously can make a meaningful difference in outcomes across all EDS types.